The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Intracellular allosteric antagonism of the CCR9 receptor
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
REFMAC 5 for the refinement of macromolecular crystal structures
Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F., & Vagin, A. A. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444911001314 · Cited by 8,317
Constant pressure molecular dynamics algorithms
Martyna, G. J., Tobias, D. J., & Klein, M. L. (1994) · The Journal of Chemical Physics · doi:10.1063/1.467468 · Cited by 5,804
Towards automated crystallographic structure refinement with phenix.refine
Afonine, P. V., Grosse-Kunstleve, R. W., Echols, N., Headd, J. J., Moriarty, N. W., Mustyakimov, M., Terwilliger, T. C., Urzhumtsev, A., Zwart, P. H., & Adams, P. D. (2012) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444912001308 · Cited by 5,511
How good are my data and what is the resolution?
Evans, P. R., & Murshudov, G. N. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913000061 · Cited by 4,697
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
Integration, scaling, space-group assignment and post-refinement
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047374 · Cited by 2,528
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Wu, B., Chien, E. Y. T., Mol, C. D., Fenalti, G., Liu, W., Katritch, V., Abagyan, R., Brooun, A., Wells, P., Bi, F. C., et al. (2010) · Science · doi:10.1126/science.1194396 · Cited by 1,782
Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser
Kang, Y., Zhou, X. E., Gao, X., He, Y., Liu, W., Ishchenko, A., Barty, A., White, T. A., Yefanov, O., Han, G. W., et al. (2015) · Nature · doi:10.1038/nature14656 · Cited by 807
Kawate, T., & Gouaux, E. (2006) · Structure · doi:10.1016/j.str.2006.01.013 · Cited by 727
Structure of the CCR5 Chemokine Receptor–HIV Entry Inhibitor Maraviroc Complex
Tan, Q., Zhu, Y., Li, J., Chen, Z., Han, G. W., Kufareva, I., Li, T., Ma, L., Fenalti, G., Li, J., et al. (2013) · Science · doi:10.1126/science.1241475 · Cited by 712
Crystallizing membrane proteins using lipidic mesophases
Caffrey, M., & Cherezov, V. (2009) · Nature Protocols · doi:10.1038/nprot.2009.31 · Cited by 670
Dancing to the tune of chemokines
Thelen, M. (2001) · Nature Immunology · doi:10.1038/84224 · Cited by 618
Conformational thermostabilization of the β1-adrenergic receptor in a detergent-resistant form
Serrano-Vega, M. J., Magnani, F., Shibata, Y., & Tate, C. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711253105 · Cited by 422
Structure of class B GPCR corticotropin-releasing factor receptor 1
Hollenstein, K., Kean, J., Bortolato, A., Cheng, R. K. Y., Doré, A. S., Jazayeri, A., Cooke, R. M., Weir, M., & Marshall, F. H. (2013) · Nature · doi:10.1038/nature12357 · Cited by 416
Self-citationAlva, V., Nam, S.-Z., Söding, J., & Lupas, A. N. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw348 · Cited by 373
Allosteric Modulation as a Unifying Mechanism for Receptor Function and Regulation
Changeux, J.-P., & Christopoulos, A. (2016) · Cell · doi:10.1016/j.cell.2016.08.015 · Cited by 336
Structural insights into agonist-induced activation of G-protein-coupled receptors
Deupi, X., & Standfuss, J. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.06.002 · Cited by 234
Better models by discarding data?
Diederichs, K., & Karplus, P. A. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913001121 · Cited by 218
Extra-helical binding site of a glucagon receptor antagonist
Jazayeri, A., Doré, A. S., Lamb, D., Krishnamurthy, H., Southall, S. M., Baig, A. H., Bortolato, A., Koglin, M., Robertson, N. J., Errey, J. C., et al. (2016) · Nature · doi:10.1038/nature17414 · Cited by 216
Self-citationUnifying Family A GPCR Theories of Activation
Tehan, B. G., Bortolato, A., Blaney, F. E., Weir, M. P., & Mason, J. S. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.004 · Cited by 196
Self-citationWalters, M. J., Wang, Y., Lai, N., Baumgart, T., Zhao, B. N., Dairaghi, D. J., Bekker, P. J., Ertl, L. S., Penfold, M. E. T., Jaén, J. C., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.169714 · Cited by 173
Robertson, N. J., Jazayeri, A., Errey, J. C., Baig, A. H., Hurrell, E., Zhukov, A., Langmead, C. J., Weir, M., & Marshall, F. H. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.001 · Cited by 163
Self-citationLazaar, A. L., Sweeney, L. E., MacDonald, A. J., Alexis, N. E., Chen, C., & Tal‐Singer, R. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03968.x · Cited by 157
Pharmacological Characterization of Sch527123, a Potent Allosteric CXCR1/CXCR2 Antagonist
Gonsiorek, W., Fan, X., Hesk, D., Fossetta, J. D., Qiu, H., Jakway, J. P., Billah, M. M., Dwyer, M. P., Chao, J., Deno, G., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.118927 · Cited by 130
Chemokine Receptor-Specific Antibodies in Cancer Immunotherapy: Achievements and Challenges
Vela, M., Aris, M., Llorente, M., García‐Sanz, J. A., & Kremer, L. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00012 · Cited by 114
Chemokine Receptor Antagonists
Pease, J. E., & Horuk, R. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300682j · Cited by 111
Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells
Tchernychev, B., Ren, Y., Sachdev, P., Janz, J. M., Haggis, L., O’Shea, A., McBride, E., Looby, R. J., Deng, Q., McMurry, T. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009633108 · Cited by 109
Membrane protein orientation and refinement using a knowledge-based statistical potential
Nugent, T., & Jones, D. T. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-276 · Cited by 106
A common intracellular allosteric binding site for antagonists of the CXCR2 receptor
Salchow, K., Bond, M., Evans, S., Press, N., Charlton, S. J., Hunt, P. A., & Bradley, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00623.x · Cited by 93
“Chemokine receptors as therapeutic targets: Why aren’t there more drugs?”
Solari, R. C. E., Pease, J. E., & Begg, M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.06.060 · Cited by 91
Andrews, G., Jones, C., & WREGGETT, K. A. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.039321 · Cited by 90
CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease
Keshav, S., & Wendt, E. (2015) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s48305 · Cited by 86
Nicholls, D., Tomkinson, N. P., Wiley, K. E., Brammall, A., Bowers, L., Grahames, C., Gaw, A. J., Meghani, P., Shelton, P. A., Wright, T. J., et al. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.044610 · Cited by 84
Targeting chemokine receptors in allergic disease
Pease, J. E. (2011) · Biochemical Journal · doi:10.1042/bj20101132 · Cited by 77
CCR5 Antagonism in HIV Infection: Current Concepts and Future Opportunities
Wilkin, T. J., & Gulick, R. M. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-052010-145454 · Cited by 66
Cited by
A guide to chemokines and their receptors
Hughes, C. E., & Nibbs, R. J. B. (2018) · The FEBS Journal · doi:10.1111/febs.14466 · Cited by 1,412
Biased signalling: from simple switches to allosteric microprocessors
Smith, J. S., Lefkowitz, R. J., & Rajagopal, S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.229 · Cited by 738
Common activation mechanism of class A GPCRs
Zhou, Q., Yang, D., Wu, M., Guo, Y., Guo, W., Zhong, L., Cai, X., Dai, A., Jang, W., Shakhnovich, E. I., et al. (2019) · eLife · doi:10.7554/elife.50279 · Cited by 632
G protein-coupled receptors: structure- and function-based drug discovery
Yang, D., Zhou, Q., Labroska, V., Qin, S., Darbalaei, S., Wu, Y., Yuliantie, E., Xie, L., Tao, H., Cheng, J., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00435-w · Cited by 632
How Ligands Illuminate GPCR Molecular Pharmacology
Wacker, D., Stevens, R. C., & Roth, B. L. (2017) · Cell · doi:10.1016/j.cell.2017.07.009 · Cited by 560
Metadata
- Authors
- Oswald, C., Rappas, M., Kean, J., Doré, A. S., Errey, J. C., Bennett, K., Deflorian, F., Christopher, J. A., Jazayeri, A., Mason, J. S., Congreve, M., Cooke, R. M., & Marshall, F. H.
- Venue
- Nature
- Published
- 2016-12-07
- Volume
- 540
- Issue
- 7633
- Pages
- 462-465
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2560644533
- Cited by
- 259
- References
- 39
- FWCI
- 15.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.